Abstract
Objective
The purpose of this study was to evaluate the diagnostic efficacy of Xpert MTB/RIF for tuberculous pericarditis (TBP).
Methods
We searched relevant databases for Xpert MTB/RIF for TBP diagnosis until April 2021 and screened eligible studies for study inclusion. We evaluated the effectiveness of Xpert MTB/RIF when the composite reference standard (CRS) and mycobacterial culture were the gold standards, respectively. We performed meta-analyses using a bivariate random-effects model, and when the heterogeneity was obvious, the source of heterogeneity was further discussed.
Results
We included seven independent studies comparing Xpert MTB/RIF with the CRS and six studies comparing it with culture. The pooled sensitivity, specificity, and area under the curve of Xpert MTB/RIF were 65% (95% confidence interval, 59–72%), 99% (97–100%), and 0.99 (0.97–0.99) as compared with the CRS, respectively, and 75% (53–88%), 99% (90–100%), and 0.94 (0.92–0.96) as compared with culture, respectively. There was no significant heterogeneity between studies when CRS was the gold standard, whereas heterogeneity was evident when culture was the gold standard.
Conclusions
The sensitivity of Xpert MTB/RIF for diagnosing TBP was moderate and the specificity was good; thus, Xpert MTB/RIF can be used in the initial diagnosis of TBP.
Funder
Hangzhou Science and Technology Bureau
Zhejiang Traditional Chinese Medicine Administration
Publisher
Public Library of Science (PLoS)
Reference48 articles.
1. World Health Organization. Global tuberculosis report 2020. Geneva, Switzerland; 2020.
2. Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus;K Ronacher;Immunol Rev,2015
3. Extrapulmonary tuberculosis;W Ketata;Rev Pneumol Clin,2015
4. Tuberculous pericarditis with and without HIV;M Ntsekhe;Heart Fail Rev,2013
5. A modern approach to tuberculous pericarditis;FF Syed;Prog Cardiovasc Dis,2007
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献